G G Neznamov - JoVE Visualize

Showing results (41-50 of 46) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 46 results.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|October 19, 2019

[Results of a clinical study of a new anxiolytic, a blocker of central cholecystokinin receptors]G G Neznamov, O A Dorofeeva, M V Metlina, et al.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|June 4, 2009

[Ladasten, the new drug with psychostimulant and anxiolytic actions in treatment of neurasthenia (results of the comparative clinical study with placebo)]G G Neznamov, S A Siuniakov, S E Teleshova, et al.

Eksperimental'Naia I Klinicheskaia Farmakologiia|September 6, 2013

[Clinic pharmacokinetics of a new original antipsychotic drug Dilept]R V Shevchenko, A A Litvin, G B Kolyvanov, et al.

Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|January 16, 1999

[The pharmacogenetic concept of the anxio-selective effect]S B Seredenin, T A Voronina, G G Neznamov, et al.

Eksperimental'Naia I Klinicheskaia Farmakologiia|July 1, 1997

[The therapeutic efficacy and the effect of gidazepam and fenazepam on the psychophysiological status and on the performance of operators with mental disorders at a neurotic level]G G Neznamov, I S Morozov, V G Barchukov, et al.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|May 6, 2008

[Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia]A A Zozulia, G G Neznamov, T S Siuniakov, et al.

Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 46 results.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|October 19, 2019

[Results of a clinical study of a new anxiolytic, a blocker of central cholecystokinin receptors]G G Neznamov, O A Dorofeeva, M V Metlina, et al.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|June 4, 2009

[Ladasten, the new drug with psychostimulant and anxiolytic actions in treatment of neurasthenia (results of the comparative clinical study with placebo)]G G Neznamov, S A Siuniakov, S E Teleshova, et al.

Eksperimental'Naia I Klinicheskaia Farmakologiia|September 6, 2013

[Clinic pharmacokinetics of a new original antipsychotic drug Dilept]R V Shevchenko, A A Litvin, G B Kolyvanov, et al.

Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|January 16, 1999

[The pharmacogenetic concept of the anxio-selective effect]S B Seredenin, T A Voronina, G G Neznamov, et al.

Eksperimental'Naia I Klinicheskaia Farmakologiia|July 1, 1997

[The therapeutic efficacy and the effect of gidazepam and fenazepam on the psychophysiological status and on the performance of operators with mental disorders at a neurotic level]G G Neznamov, I S Morozov, V G Barchukov, et al.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|May 6, 2008

[Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia]A A Zozulia, G G Neznamov, T S Siuniakov, et al.

Pageof 5